A clinical trial involving insulin lispro was reported as completed, with an update dated August 25, 2026. The study, registered as NCT07786064, is titled "Comparative Study of the Postprandial Glycemic Profile After Consumption of a High-fat Meal (Pizza) Between the Open-loop System (Medtronic MiniMed 640G) and the Hybrid Closed-loop System (Medtronic MiniMed 780G) in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Pumps."
The trial evaluated patients with type 1 diabetes who use continuous subcutaneous insulin infusion pumps delivering insulin lispro. It compared an open-loop pump system, the Medtronic MiniMed 640G, against a hybrid closed-loop system, the Medtronic MiniMed 780G. The listed phase for this study is not applicable.
The trial status is recorded as completed as of the given date. No results, outcomes, or efficacy data are included in this update. This brief reflects only the status change and study description as registered.
Readers seeking more background on insulin lispro can consult the compound overview for additional context.